Covid: Under-30s offered alternative to Oxford-AstraZeneca jab

A review finds a “plausible” link to rare blood clots, but says the jab remains beneficial for most.

About the Author

has written 41789 stories on this site.

Copyright © 2010 Business and Corporate News.